(Q35544340)

8 August 2017

1 reference

title

Tolerability and safety of eletriptan in the treatment of migraine: a comprehensive review (English)

1 reference

8 August 2017

Tolerability and Safety of Eletriptan in the Treatment of Migraine: A Comprehensive Review (English)

1 reference

https://api.crossref.org/works/10.1046/J.1526-4610.2003.03188.X

14 March 2024

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1046/J.1526-4610.2003.03188.X

14 March 2024

author name string

Jayasena Hettiarachchi

2

1 reference

8 August 2017

Jeffrey Alderman

3

1 reference

8 August 2017

Ninan T. Mathew

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14511273

14 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14511273

14 March 2024

publication date

1 October 2003

1 reference

full work available at URL

8 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1526-4610.2003.03188.x

1 reference

https://api.crossref.org/works/10.1046/J.1526-4610.2003.03188.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1526-4610.2003.03188.x

14 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1526-4610.2003.03188.X

https://onlinelibrary.wiley.com/doi/full-xml/10.1046/j.1526-4610.2003.03188.x

14 March 2024

1 reference

https://api.crossref.org/works/10.1046/J.1526-4610.2003.03188.X

14 March 2024

1 reference

8 August 2017

volume

43

1 reference

8 August 2017

issue

9

1 reference

8 August 2017

page(s)

962-974

1 reference

Eletriptan in acute migraine: a double-blind, placebo-controlled comparison to sumatriptan. Eletriptan Steering Committee.

8 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03188.X

Eletriptan vs sumatriptan: a double-blind, placebo-controlled, multiple migraine attack study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03188.X

Migraine in the United States: epidemiology and patterns of health care use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03188.X

Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries. 5-HT1-like receptors resemble cloned 5-HT1D beta receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03188.X

Serotonin-induced hypercontraction through 5-hydroxytryptamine 1B receptors in atherosclerotic rabbit coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1526-4610.2003.03188.X

Comparative efficacy of eletriptan 40 mg versus sumatriptan 100 mg.

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1046/J.1526-4610.2003.03188.X

Efficacy, tolerability and safety of oral eletriptan and ergotamine plus caffeine (Cafergot) in the acute treatment of migraine: a multicentre, randomised, double-blind, placebo-controlled comparison

14 March 2024

4

1 reference

https://api.crossref.org/works/10.1046/J.1526-4610.2003.03188.X

Characterisation of the 5-HT receptor binding profile of eletriptan and kinetics of [3H]eletriptan binding at human 5-HT1B and 5-HT1D receptors

14 March 2024

7

1 reference

https://api.crossref.org/works/10.1046/J.1526-4610.2003.03188.X

Pharmacokinetics, pharmacodynamics, and safety of the 5-HT(1B/1D) agonist eletriptan following intravenous and oral administration

14 March 2024

8

1 reference

https://api.crossref.org/works/10.1046/J.1526-4610.2003.03188.X

Prevalence and burden of migraine in the United States: data from the American Migraine Study II.

14 March 2024

9

1 reference

https://api.crossref.org/works/10.1046/J.1526-4610.2003.03188.X

Headache and major depression: is the association specific to migraine?

14 March 2024

10

1 reference

https://api.crossref.org/works/10.1046/J.1526-4610.2003.03188.X

Characterisation of 5-HT receptors in human coronary arteries by molecular and pharmacological techniques

14 March 2024

11

1 reference

https://api.crossref.org/works/10.1046/J.1526-4610.2003.03188.X

No contractile effect for 5-HT1D and 5-HT1F receptor agonists in human and bovine cerebral arteries: similarity with human coronary artery

14 March 2024

13

1 reference

https://api.crossref.org/works/10.1046/J.1526-4610.2003.03188.X

Comparison of the vasoconstrictor effects of the selective 5-HT1D-receptor agonist L-775,606 with the mixed 5-HT1B/1D-receptor agonist sumatriptan and 5-HT in human isolated coronary artery

14 March 2024

15

1 reference

https://api.crossref.org/works/10.1046/J.1526-4610.2003.03188.X

Comparative effects of frovatriptan and sumatriptan on coronary and internal carotid vascular haemodynamics in conscious dogs

14 March 2024

16

1 reference

https://api.crossref.org/works/10.1046/J.1526-4610.2003.03188.X

Craniovascular selectivity of eletriptan and sumatriptan in human isolated blood vessels

14 March 2024

19

1 reference

https://api.crossref.org/works/10.1046/J.1526-4610.2003.03188.X

Coronary vasoconstriction induced by mental stress (simulated public speaking).

14 March 2024

21

1 reference

https://api.crossref.org/works/10.1046/J.1526-4610.2003.03188.X

Hemodynamic and coronary effects of intravenous eletriptan, a 5HT1B/1D-receptor agonist

14 March 2024

22

1 reference

https://api.crossref.org/works/10.1046/J.1526-4610.2003.03188.X

Role of transport proteins in drug absorption, distribution and excretion

14 March 2024

23

1 reference

https://api.crossref.org/works/10.1046/J.1526-4610.2003.03188.X

14 March 2024

Identifiers

1 reference

8 August 2017

1 reference